[Recombinant human erythropoietin (KRN5702) therapy for autologous blood transfusion in patients with rheumatoid arthritis undergoing joint replacement surgery--a multicenter phase II clinical trial].
Ryumachi
; 34(3): 583-93, 1994 Jun.
Article
in Ja
| MEDLINE
| ID: mdl-8052924
Search on Google
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Hemoterapia
Main subject:
Arthritis, Rheumatoid
/
Blood Transfusion, Autologous
/
Erythropoietin
/
Joint Prosthesis
Type of study:
Clinical_trials
Country/Region as subject:
Asia
Language:
Ja
Journal:
Ryumachi
Year:
1994
Type:
Article